Linagliptin-treated rats exhibited significant improvement in impaired LV diastolic function, as well as endothelial function of gastrocnemius feed arteries, and, somewhat surprisingly, this was associated with a reduction in BP [34]
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: a meta-analysis and meta-regression analysis
Again, that would typically be a good thing, suggesting that folks taking compounded versions could switch to the brand-name options, which carry the added safety of having gone through the FDA approval process (more on this below)
Every clinic promises results, yet many leave out key details or push you toward the Price-Safety Trap where costs rise and support fades
Other medications like Xenical, which reduces the absorption of fat, may be a good fit for people who are looking to reduce their calorie intake or who might not tolerate the GLP-1 drugs